Home › U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen...
 

Keywords :   


U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen...

2013-12-14 19:29:39| Biotech - Topix.net

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera for use in certain virologically-suppressed and St. John's wort.

Tags: single tablet fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
More »